You are here: Industry Insights > Curia

News List

Integrity Bio and LakePharma Become Curia contractpharma
February 14, 2022
Companies unite under one brand to provide comprehensive biologics discovery, development and manufacturing services.
Curia Launches Comprehensive mRNA Offering contractpharma
December 22, 2021
mRNA services combine experience and capabilities from discovery through fill-finish manufacturing.
Curia lays out plans to expand complex API manufacturing capacity cphi-online
August 23, 2021
The $35 million investment will more than double the site’s batch-size scaling and product output.
Curia to Acquire US-based LakePharma contractpharma
July 15, 2021
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, has entered an agreement to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing ...
Curia to buy fellow CDMO Integrity Bio cphi-online
July 15, 2021
Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network
Curia to Acquire Integrity Bio contractpharma
July 14, 2021
Curia, formerly AMRI, a contract research, development and manufacturing organization, has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately held formulation and fill-finish company headquartered in Camarillo, CA.
AMRI Becomes Curia contractpharma
July 13, 2021
Albany Molecular Research, Inc. (AMRI), a global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, is changing its name to Curia, effective July 12, 2021.